These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12238004)

  • 1. [Problem with restenosis in connection to balloon angioplasty near to be solved].
    Aalto T; Stjernvall J
    Duodecim; 2002; 118(10):977-8. PubMed ID: 12238004
    [No Abstract]   [Full Text] [Related]  

  • 2. Sirolimus-eluting coronary stents.
    Drenth DJ; Zijlstra F; Boonstra PW
    N Engl J Med; 2004 Jan; 350(4):413-4; author reply 413-4. PubMed ID: 14743520
    [No Abstract]   [Full Text] [Related]  

  • 3. Sirolimus-eluting coronary stents.
    Mack MJ
    N Engl J Med; 2004 Jan; 350(4):413-4; author reply 413-4. PubMed ID: 14736936
    [No Abstract]   [Full Text] [Related]  

  • 4. Another attempt to deal with restenosis.
    Colombo A
    Catheter Cardiovasc Interv; 2005 Apr; 64(4):419-20. PubMed ID: 15789392
    [No Abstract]   [Full Text] [Related]  

  • 5. Restenosis in percutaneous coronary intervention--is drug-eluting stent the answer?
    Lim VY; Lim YL
    Singapore Med J; 2003 Sep; 44(9):482-7. PubMed ID: 14740779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PTCA with drug eluting stent. 90% fewer restenoses in high risk patients].
    MMW Fortschr Med; 2004 Aug; 146(33-34):53. PubMed ID: 15526636
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of restenosis after coronary stenting, problem soon resolved].
    Kivelä A; Hartikainen J
    Duodecim; 2005; 121(11):1227-36. PubMed ID: 15999982
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-eluting stents: preventing restenosis.
    Slavin L; Chhabra A; Tobis JM
    Cardiol Rev; 2007; 15(1):1-12. PubMed ID: 17172878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stent fracture-unusual cause of DES restenosis.
    Goyal BK
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):993-4. PubMed ID: 17525958
    [No Abstract]   [Full Text] [Related]  

  • 10. [Do vascular stents solve the restenosis problem? You are too optimistic!].
    Kleinertz K
    MMW Fortschr Med; 2002 Aug; 144(31-32):12. PubMed ID: 12422722
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of sirolimus-eluting stents in diabetics with complex coronary lesions].
    Berenguer A; Mainar V; Bordes P; Valencia J; Gómez S
    Rev Esp Cardiol; 2006 Feb; 59(2):117-24. PubMed ID: 16540032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed strut fracture of sirolimus-eluting stent: a significant problem or an occasional observation?
    Min PK; Yoon YW; Moon Kwon H
    Int J Cardiol; 2006 Jan; 106(3):404-6. PubMed ID: 16337054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
    Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
    Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique".
    Moussa I; Costa RA; Leon MB; Lansky AJ; Lasic Z; Cristea E; Trubelja N; Carlier SG; Mehran R; Dangas GD; Weisz G; Kreps EM; Collins M; Stone GW; Moses JW
    Am J Cardiol; 2006 May; 97(9):1317-21. PubMed ID: 16635603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome].
    Gil RJ
    Kardiol Pol; 2005 Nov; 63(5):574-6; discussion 577. PubMed ID: 16362868
    [No Abstract]   [Full Text] [Related]  

  • 16. TCT Daily: ZOMAXX I--mixed results with zotarolimus-eluting stent.
    J Interv Cardiol; 2007 Feb; 20(1):35. PubMed ID: 17300399
    [No Abstract]   [Full Text] [Related]  

  • 17. Percutaneous stenting of the left main with drug eluting stents for in-stent restenosis: immediate- and long-term results.
    Mixon T; Fitzsimmons P
    J Invasive Cardiol; 2006 Jun; 18(6):E166-8. PubMed ID: 16775892
    [No Abstract]   [Full Text] [Related]  

  • 18. Creatine kinase-myocardial band isoenzyme elevation after percutaneous coronary interventions using sirolimus-eluting stents.
    Stankovic G; Chieffo A; Iakovou I; Orlic D; Corvaja N; Sangiorgi G; Airoldi F; Colombo A
    Am J Cardiol; 2004 Jun; 93(11):1397-401, A9. PubMed ID: 15165923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stent: the emerging technique for the prevention of restenosis.
    Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
    Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous treatment of coronary bifurcation lesions: a novel "extended Y" technique with complete lesion stent coverage.
    Helqvist S; Jørgensen E; Kelbaek H; Aljabbari S; Thuesen L; Flensted Lassen J; Saunamäki K
    Heart; 2006 Jul; 92(7):981-2. PubMed ID: 16775110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.